Research Article

Evaluation of Hemogram, Biochemistry, Inflammatory Markers and Electrolyte Levels in Patients with Acute Myocardial Infarction

Volume: 5 Number: 2 July 1, 2023
EN TR

Evaluation of Hemogram, Biochemistry, Inflammatory Markers and Electrolyte Levels in Patients with Acute Myocardial Infarction

Abstract

Objective: Hemogram, biochemistry, serum electrolyte, and inflammatory marker levels are altered in patients with acute myocardial infarction. When diagnosing and monitoring patients with acute myocardial infarction using cardiac-specific biomarkers, the levels of these markers should also be under control. We looked into the diagnostic and therapeutic value of hemogram, biochemistry, inflammatory markers, and electrolyte levels in acute myocardial infarction patients. Material and Method: It is a descriptive epidemiological study. Within the scope of the study, all patients aged 18 years and over and diagnosed with acute myocardial infarction in the Emergency Department and Cardiology Department of Kahramanmaraş Sütçü İmam University Faculty of Medicine Hospital between 01.01.2022 - 31.12.2022 were included retrospectively. Hemogram, biochemistry, serum electrolyte and inflammatory marker levels were investigated in acute myocardial infarction patients. Results: Leukocyte, neutrophil, procalcitonin and C-reactive protein values were significantly higher in patients with acute myocardial infarction. Although platelet/lymphocyte ratios were high, no significance was found. In patients with acute myocardial infarction, glucose values measured at the time of stress were found to be high (hyperglycaemia). When we analysed the serum lactate levels of patients with acute myocardial infarction, it was found to be significantly higher. Conclusion: In patients with acute myocardial infarction, hemogram, biochemistry, serum electrolyte and inflammatory marker levels are altered. The levels of these markers should also be controlled during the diagnosis and follow-up of acute myocardial infarction patients with cardiac specific biomarkers. We believe that hemogram, biochemistry, inflammatory markers and electrolyte levels may contribute to the prediction of early serious complications in patients with acute myocardial infarction.

Keywords

References

  1. AHA Statistical Update Heart Disease and Stroke Statistics. A Report From the American Heart Association. 2012 Update.
  2. AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 2022 Update.
  3. Bassand JP, Christian WH, Diego A, Eric B. ST Segment Yükselmesi Olmayan Akut Koroner Sendromların Tanı ve Tedavi Kılavuzu. European Heart Journal. 2007; 28: 1598–1660. doi:10.1093/eurheartj/ehm161
  4. Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol. 2004 Jan 21;43(2):155-61. doi: 10.1016/j.jacc.2003.06.021.
  5. Young B, Lin H, Mc Cabe RD. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology. 1995: 68(4); 825.
  6. Eisner D, Bode E, Venetucci L, Trafford A. Calcium flux balance in the heart. J Mol Cell Cardiol. 2013: 58; 110–7.
  7. Cohen HW, Hailpern SM, Alderman MH. Sodium intake and mortality follow-up in the Third National Health and Nutrition Examination Survey (NHANES III). J Gen Intern Med. 2008; 23: 1297–1302.
  8. Murat K, Çiğdem E, Nizameddin K. Stres Hiperglisemisinin Akut Miyokard Enfarktüsünün Prognozuna Etkisinin Değerlendirilmesi. Metabolik Sendrom Derneği: XVII. Metabolik Sendrom Sempozyumu; 24-28 Kasım 2020, SS-09.

Details

Primary Language

English

Subjects

Clinical Sciences, Emergency Medicine

Journal Section

Research Article

Publication Date

July 1, 2023

Submission Date

May 15, 2023

Acceptance Date

May 26, 2023

Published in Issue

Year 2023 Volume: 5 Number: 2

APA
Gedik, M. S., & Göçer, K. (2023). Evaluation of Hemogram, Biochemistry, Inflammatory Markers and Electrolyte Levels in Patients with Acute Myocardial Infarction. Phoenix Medical Journal, 5(2), 107-112. https://doi.org/10.38175/phnx.1297449
AMA
1.Gedik MS, Göçer K. Evaluation of Hemogram, Biochemistry, Inflammatory Markers and Electrolyte Levels in Patients with Acute Myocardial Infarction. Phnx Med J. 2023;5(2):107-112. doi:10.38175/phnx.1297449
Chicago
Gedik, Muhammed Semih, and Kemal Göçer. 2023. “Evaluation of Hemogram, Biochemistry, Inflammatory Markers and Electrolyte Levels in Patients With Acute Myocardial Infarction”. Phoenix Medical Journal 5 (2): 107-12. https://doi.org/10.38175/phnx.1297449.
EndNote
Gedik MS, Göçer K (July 1, 2023) Evaluation of Hemogram, Biochemistry, Inflammatory Markers and Electrolyte Levels in Patients with Acute Myocardial Infarction. Phoenix Medical Journal 5 2 107–112.
IEEE
[1]M. S. Gedik and K. Göçer, “Evaluation of Hemogram, Biochemistry, Inflammatory Markers and Electrolyte Levels in Patients with Acute Myocardial Infarction”, Phnx Med J., vol. 5, no. 2, pp. 107–112, July 2023, doi: 10.38175/phnx.1297449.
ISNAD
Gedik, Muhammed Semih - Göçer, Kemal. “Evaluation of Hemogram, Biochemistry, Inflammatory Markers and Electrolyte Levels in Patients With Acute Myocardial Infarction”. Phoenix Medical Journal 5/2 (July 1, 2023): 107-112. https://doi.org/10.38175/phnx.1297449.
JAMA
1.Gedik MS, Göçer K. Evaluation of Hemogram, Biochemistry, Inflammatory Markers and Electrolyte Levels in Patients with Acute Myocardial Infarction. Phnx Med J. 2023;5:107–112.
MLA
Gedik, Muhammed Semih, and Kemal Göçer. “Evaluation of Hemogram, Biochemistry, Inflammatory Markers and Electrolyte Levels in Patients With Acute Myocardial Infarction”. Phoenix Medical Journal, vol. 5, no. 2, July 2023, pp. 107-12, doi:10.38175/phnx.1297449.
Vancouver
1.Muhammed Semih Gedik, Kemal Göçer. Evaluation of Hemogram, Biochemistry, Inflammatory Markers and Electrolyte Levels in Patients with Acute Myocardial Infarction. Phnx Med J. 2023 Jul. 1;5(2):107-12. doi:10.38175/phnx.1297449

2392_ccby-295.jpg
Phoenix Medical Journal is licensed under a Creative Commons Attribution 4.0 International License.


2392_boai-189.jpg

Phoenix Medical Journal has signed the Budapest Open Access Declaration.